What is the recommended typhoid vaccine protocol for adults, including dosing, schedule, booster timing, and contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Typhoid Vaccine Protocol in Adults

For adults ≥10 years, administer either oral Ty21a vaccine (4 capsules on alternate days) OR parenteral Vi polysaccharide vaccine (single 0.5 mL subcutaneous dose), with boosters every 5 years for oral or every 3 years for injectable formulations.

Primary Vaccination Options

Adults have two well-established vaccine choices 1:

Oral Live-Attenuated Ty21a Vaccine (Preferred for tolerability)

  • Dosing: 4 enteric-coated capsules total
  • Schedule: One capsule every other day (days 1,3,5,7)
  • Administration: Take with cool liquid ≤37°C (≤98.6°F), approximately 1 hour before meals
  • Storage: Must be refrigerated
  • Critical: All 4 doses must be completed for maximum efficacy
  • Efficacy: Prevents approximately 50% of typhoid cases over 2.5-3 years (cumulative efficacy 50%, 95% CI 35-61%) 2

Parenteral Vi Polysaccharide Vaccine (Injectable)

  • Dosing: 0.5 mL subcutaneous injection
  • Schedule: Single dose (traditional 2-dose schedule separated by ≥4 weeks is outdated)
  • Efficacy: Prevents 69% of cases in year 1 (95% CI 63-74%) and 59% in year 2 (95% CI 45-69%) 2
  • Alternative accelerated schedule: If insufficient time, 3 doses at weekly intervals (less effective) 1

Booster Recommendations

For Oral Ty21a Vaccine

  • Timing: Repeat full 4-dose series every 5 years if continued exposure 1
  • Longest documented efficacy is 5 years post-vaccination 1

For Parenteral Vi Polysaccharide Vaccine

  • Timing: Single booster dose every 3 years if continued exposure 1
  • Even if >3 years elapsed, only one booster dose needed (not restart series)
  • Route options: 0.5 mL subcutaneous OR 0.1 mL intradermal (intradermal causes less reaction with heat-phenol-inactivated formulation) 1

Indications for Vaccination

Selective vaccination is recommended for 1:

  1. Travelers to endemic areas (Latin America, Asia, Africa) with prolonged exposure to potentially contaminated food/water
  2. Household contacts of documented typhoid carriers
  3. Laboratory workers frequently handling S. typhi
  4. Residents of endemic areas (sewage workers only in endemic regions)

Not indicated: Rural summer camps, natural disaster areas, common-source outbreak control 1

Contraindications and Precautions

Oral Ty21a Vaccine

  • Absolute contraindication: Immunocompromised persons, including HIV-infected individuals 1
  • Pregnancy: No safety data; avoid 1
  • Side effects: Rare—abdominal discomfort, nausea, vomiting, rash occurred at same frequency as placebo 1

Parenteral Vi Polysaccharide Vaccine

  • Absolute contraindication: History of severe local/systemic reactions to previous dose 1
  • Pregnancy: No safety data; theoretically safer than live vaccine for immunocompromised 1
  • Common side effects 1:
    • Fever: 14-29% of vaccinees
    • Headache: 9-30%
    • Severe local pain/swelling: 6-40%
    • Work/school absence: 13-24%
  • Rare severe reactions: Hypotension, chest pain, shock 1

Critical Clinical Pitfalls

  1. Vaccine is not 100% effective: Counsel patients that careful food/water selection remains essential—vaccine protection can be overwhelmed by large inocula 1

  2. Oral vaccine storage: Ty21a capsules must remain refrigerated; failure to do so compromises efficacy 1

  3. Timing for travelers: Complete vaccination series at least 1-2 weeks before departure for optimal immunity

  4. Avoid acetone-inactivated vaccine intradermally: Causes severe local reactions 1

  5. Do not use TAB vaccines: Paratyphoid A/B antigens are ineffective and increase reaction risk—only monovalent S. typhi preparations should be used 1

Emerging Evidence

Recent research suggests newer typhoid conjugate vaccines (TCVs) may offer improved protection, particularly in children 3, 4, 5. However, the established Ty21a and Vi polysaccharide vaccines remain the standard for adults based on decades of efficacy data 2. The WHO has recommended Vi-TT conjugate vaccines, but field efficacy data in adults with natural exposure remains limited 2.

Note: The evidence base primarily derives from 1990 ACIP guidelines [1-1], which remain the authoritative source for these established vaccines, supplemented by more recent systematic reviews confirming their continued efficacy 2.

References

2
Research

Vaccines for preventing typhoid fever.

The Cochrane database of systematic reviews, 2018

5
Research

Typhoid conjugate vaccines for preventing typhoid fever (enteric fever).

The Cochrane database of systematic reviews, 2025

Related Questions

What is the effectiveness of typhoid (Typhoid fever) vaccines?
After how long can a patient with enteric (typhoid) fever be vaccinated against typhoid?
Which vaccine is more likely to cause same-day onset fever in a 6-month-old infant, Influvac Tetra (influenza vaccine) or Typhoid Conjugate Vaccine (TCV)?
What is the recommended dose and administration schedule for the oral Ty21a typhoid vaccine in individuals aged six years and older?
How long is the typhoid (Salmonella Typhi) vaccine effective?
In a 30-year-old woman presenting with sudden chest discomfort, blood pressure 130/90 mmHg, platelet count approximately 40 × 10⁹/L, normal troponin I, and rapid progression to cardiac arrest, can aortic dissection serve as an overall explanation for the severe thrombocytopenia?
What is the appropriate treatment for a patient with chronic obstructive pulmonary disease experiencing an acute exacerbation?
How can I determine whether a patient has previously been vaccinated for typhoid?
Can a female patient with a remote anteroseptal myocardial infarction (MI) who is asymptomatic, has normal blood pressure, a two‑dimensional echocardiogram showing concentric remodeling with preserved systolic function, and a normal stress echocardiogram be cleared for employment?
Can you provide an example endoscopy report for a 58‑year‑old male with a gastric gastrointestinal stromal tumor, describing the lesion size, depth of invasion, involvement of the adjacent duodenum and pancreas, and the presence or absence of lymphadenopathy or distant metastases?
What diagnosis should be written on the clearance for a patient with a remote (old) anteroseptal myocardial infarction, who is asymptomatic, has preserved left‑ventricular systolic function, concentric remodeling, and a normal stress echocardiogram showing no inducible ischemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.